NEW YORK, May 7, 2021 /PRNewswire/ -- Petros
Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of
therapeutics for men's health, today announced that management will
participate at the Benzinga Global Small Cap Conference on
May 13, 2021.
President and Chief Commercial Officer Fady Boctor will deliver
his corporate presentation at 10:50am
ET on May 13, 2021.
Investors can also request a one-on-one meeting with Mr. Boctor
to be arranged following the conclusion of the conference.
Investors can register for the conference here:
https://www.benzinga.com/events/small-cap/global/.
About Petros Pharmaceuticals
Petros Pharmaceuticals is
committed to the goal of becoming a world-leading specialized men's
health company by identifying, developing, acquiring, and
commercializing innovative therapeutics for men's health issues
including, but not limited to erectile dysfunction, endothelial
dysfunction, psychosexual and psychosocial ailments, Peyronie's
disease, hormone health and substance use disorders.
View original
content:http://www.prnewswire.com/news-releases/petros-pharmaceuticals-to-participate-at-the-benzinga-global-small-cap-conference-and-present-to-investors-on-may-13-2021-301286412.html
SOURCE Petros Pharmaceuticals, Inc.